CorMedix CRMD
NASDAQ CRMD
$7.19 -0.23 (-3.10%)
At close: Oct 2, 2026 · 4:00 PM EDT

CorMedix (CRMD) Price to Earnings (2020 - 2026)

Updated

CorMedix's (CRMD) Price to Earnings was 3.66 for Q2 2026, down 79.7% from 17.97 a year earlier.

Analysis

CorMedix (CRMD) Price to Earnings (2020 - 2026) Analysis & Trends

For FY2025, Price to Earnings at CorMedix was 4.59.

  • The Q2 2026 figure ranks as the lowest quarterly Price to Earnings in data going back to Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 CorMedix 558.43 Mn -94.09 Mn 77.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.66
Dec 31, 2025 5.65
Sep 30, 2025 5.61
Jun 30, 2025 17.97
Mar 31, 2025 24.28
Jun 30, 2022 10.72
Mar 31, 2022 17.10
Dec 31, 2021 13.74
Sep 30, 2020 17.67
API Access

CorMedix Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=CRMD&period=max&api_key=YOUR_API_KEY